Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lucchi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinomaG Fontanini, L Boldrini, S Vignati, et al.
The Journal of Pathology|September 1, 1995
Microvessel count predicts metastatic disease and survival in non-small cell lung cancerG Fontanini, D Bigini, S Vignati, et al.
British Journal of Cancer|March 1, 2002
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinomaG Fontanini, P Faviana, M Lucchi, et al.
Journal of the National Cancer Institute|June 18, 1997
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective studyG Fontanini, M Lucchi, S Vignati, et al.
British Journal of Cancer|August 11, 2005
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancerL Boldrini, V Donati, M Dell'Omodarme, et al.
British Journal of Cancer|January 1, 1997
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionG Fontanini, S Vignati, M Lucchi, et al.
Current Pharmaceutical Design|September 15, 2012
Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumorsJ Voortman, T Harada, R P Chang, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|November 21, 2013
Histo-cytological diagnostic accuracy in lung cancerA Proietti, L Boldrini, G Alì, et al.
Journal of Endocrinological Investigation|November 30, 2023
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatmentsA Prete, E Pieroni, E Marrama, et al.
International Journal of Oncology|December 18, 2001
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancerL Boldrini, P Faviana, S Gisfredi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinomaG Fontanini, L Boldrini, S Vignati, et al.
The Journal of Pathology|September 1, 1995
Microvessel count predicts metastatic disease and survival in non-small cell lung cancerG Fontanini, D Bigini, S Vignati, et al.
British Journal of Cancer|March 1, 2002
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinomaG Fontanini, P Faviana, M Lucchi, et al.
Journal of the National Cancer Institute|June 18, 1997
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective studyG Fontanini, M Lucchi, S Vignati, et al.
British Journal of Cancer|August 11, 2005
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancerL Boldrini, V Donati, M Dell'Omodarme, et al.
British Journal of Cancer|January 1, 1997
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionG Fontanini, S Vignati, M Lucchi, et al.
Current Pharmaceutical Design|September 15, 2012
Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumorsJ Voortman, T Harada, R P Chang, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|November 21, 2013
Histo-cytological diagnostic accuracy in lung cancerA Proietti, L Boldrini, G Alì, et al.
Journal of Endocrinological Investigation|November 30, 2023
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatmentsA Prete, E Pieroni, E Marrama, et al.
International Journal of Oncology|December 18, 2001
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancerL Boldrini, P Faviana, S Gisfredi, et al.
Pageof 8